Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis

[11] Silverstein DM(1999)Expression of the CC chemokine receptor 5 in human kidney diseases Kidney Int 56 52-64

[12] Raman D(2003)Chemokines and chemokine receptors are involved in the resolution or progression of renal disease Kidney Int 63 401-415

[13] Sobolik-Delmaire T(2001)CC chemokine receptor 5 and renal-transplant survival Lancet 357 1758-1761

[14] Richmond A(2011)Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity Obesity 19 222-227

[15] Segerer S(2015)Relationship of genetic polymorphisms of the chemokine, CCL5, and its receptor, CCR5, with coronary artery disease in Taiwan Evid Based Complement Altern Med 2015 851683-758

[16] Nelson PJ(2015)Metabolic effects of CX3CR1 deficiency in diet-induced obese mice PLoS One 10 e0138317-S60

[17] Schlöndorff D(2002)Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation J Am Soc Nephrol 13 754-1536

[18] Zernecke A(2008)Diagnosis and classification of diabetes mellitus Diabetes Care 31 S55-172

[19] Shagdarsuren E(2007)2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J 28 1462-556

[20] Weber C(2004)Targeting the chemokine network in renal inflammation Arch Immunol Ther Exp (Warsz) 52 164-2461

[11] Silverstein DM(1999)Expression of the CC chemokine receptor 5 in human kidney diseases Kidney Int 56 52-64

[12] Raman D(2003)Chemokines and chemokine receptors are involved in the resolution or progression of renal disease Kidney Int 63 401-415

[13] Sobolik-Delmaire T(2001)CC chemokine receptor 5 and renal-transplant survival Lancet 357 1758-1761

[14] Richmond A(2011)Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity Obesity 19 222-227

[15] Segerer S(2015)Relationship of genetic polymorphisms of the chemokine, CCL5, and its receptor, CCR5, with coronary artery disease in Taiwan Evid Based Complement Altern Med 2015 851683-758

[16] Nelson PJ(2015)Metabolic effects of CX3CR1 deficiency in diet-induced obese mice PLoS One 10 e0138317-S60

[17] Schlöndorff D(2002)Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation J Am Soc Nephrol 13 754-1536

[18] Zernecke A(2008)Diagnosis and classification of diabetes mellitus Diabetes Care 31 S55-172

[19] Shagdarsuren E(2007)2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J 28 1462-556

[20] Weber C(2004)Targeting the chemokine network in renal inflammation Arch Immunol Ther Exp (Warsz) 52 164-2461